Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women
Completed · Phase 4
Conditions studied: Melasma
In brief
This study will enroll 20 adult Hispanic women. Participants will apply 4% hydroquinone cream twice daily to affected areas on the face for 14 weeks and half the face will be peeled with 20-30% salicylic acid every two weeks for a total of 4 peels. The first two peels will be 20% salicylic acid and the second two peels will be with 30% salicylic acid. The purpose of the study will be to evaluate the safety and efficacy of salicylic acid combined with 4% hydroquinone versus 4% hydroquinone alone.
Key facts
- Study ID
- NCT00616239
- Run by
- University of Texas Southwestern Medical Center
- People needed
- 20
- Starts
- 2008-01-01
- Expected to finish
- 2018-03-01
- Last updated by the study team
- 2020-08-10
Who can join
Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Hispanic women ages 18-65 years of age with moderate to severe melasma
- English and Spanish-speaking women
You may not qualify if…
- Pregnant or breast-feeding women
- Subjects who have used 4% hydroquinone within 3 months of study start
- Subjects who have used chemical peels, microdermabrasion or facial laser treatments within 9 months of study start
Where it is running
- UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.